[FDA-labelled indication?[1]] No [TGA-labelled indication?[3]] No [MHRA-labelled indication?[11]] No [Literature support] Several clinical trials have confirmed its efficacy as a monotherapy,[77] as an adjunct to tretinoin[77] and as an adjunct to hydralazine.[78] [Indications] 
Myelodysplastic syndrome